Provided by Tiger Trade Technology Pte. Ltd.

Warrior Met Coal LLC

106.73
+3.373.26%
Post-market: 106.730.00000.00%19:30 EDT
Volume:776.88K
Turnover:83.57M
Market Cap:5.61B
PE:25.66
High:109.42
Open:105.20
Low:105.03
Close:103.36
52wk High:110.39
52wk Low:54.66
Shares:52.57M
Float Shares:51.47M
Volume Ratio:1.47
T/O Rate:1.51%
Dividend:0.32
Dividend Rate:0.30%
EPS(TTM):4.16
EPS(LYR):1.08
ROE:10.04%
ROA:5.17%
PB:2.45
PE(LYR):98.82

Loading ...

Warrior Met Coal - Full Year 2026 Coal Sales Guidance 13.0-14.0 Mln Short Tons

THOMSON REUTERS
·
Aug 06

Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome

GlobeNewswire
·
Aug 03

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise

GlobeNewswire
·
Aug 03

Earning Preview: Warrior Met Coal LLC this quarter’s revenue is expected to increase by 66.90%, and institutional views are bullish

Earnings Agent
·
Jul 29

Warrior Met Coal Keeps Quarterly Dividend at $0.08 a Share, Payable Aug. 17 to Holders of Record Aug. 10

MT Newswires Live
·
Jul 29

Press Release: Warrior Announces Regular Quarterly Cash Dividend

Dow Jones
·
Jul 29

Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC

GlobeNewswire
·
Jul 22

Coal Sector Urges Trump Administration to Provide Financing for Existing, New Power Plants

Reuters
·
Jul 22

Can-Fite Positive Phase 2a Pancreatic Cancer Study Data Accepted for Presentation at ESMO Congress 2026, One of the World's Premier Scientific Meetings in Oncology

GlobeNewswire
·
Jul 20

3 U.S. Manufacturing Stocks Investors Are Watching As Brazil Tariffs Hit

Simply Wall St.
·
Jul 20

Warrior Met Coal Schedules Q2 Earnings Release, Investor Call

Reuters
·
Jul 16

Can-Fite Secures Australian Patent Allowance Supporting Namodenoson Development and Marketing in Liver and Pancreatic Cancer

GlobeNewswire
·
Jul 14

Blue Creek Completion and Supply Constraints Could Be A Game Changer For Warrior Met Coal (HCC)

Simply Wall St.
·
Jul 12

China Producer Price Pressure Puts Silvercorp Metals And Mining Stocks In Focus

Simply Wall St.
·
Jul 10

HCC Healthcare Signs Business Combination Agreement with RF Acquisition Corp III to Pursue Nasdaq Listing

GlobeNewswire
·
Jul 10

Warrior Met Coal (HCC) Gets a Buy from Jefferies

TIPRANKS
·
Jul 09

RBC Capital Sticks to Their Hold Rating for Warrior Met Coal (HCC)

TIPRANKS
·
Jul 09

Can-Fite Achieves Key Pivotal Phase 3 Psoriasis Milestone with Completion of Patient Enrolment for the Interim Analysis: Data Expected Q4 2026/Q1 2027

GlobeNewswire
·
Jul 06

Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease

GlobeNewswire
·
Jul 01

3 US Manufacturing Stocks Tied To Onshoring And Trade Tariff Shifts

Simply Wall St.
·
Jul 01